Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice
Objective: To assess socio-sanitary expenditure after the addition of omalizumab to standard treatment in the control of severe asthma and to analyse its effectiveness under standard clinical practice. Method: Observational retrospective multicentre study conducted in 12 pneumology services in th...
Saved in:
| Main Authors: | Eva Martínez-Moragón, María Climent, Eusebi Chiner, Cleofé Fernández-Aracil, Fernando Sánchez-Toril, Inmaculada Lluch-Tortajada |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-05-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/11167.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
by: A. Arrobas, et al.
Published: (2021-03-01) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021-08-01) -
Health care resource utilization of patients with asthma and food allergy initiating omalizumab
by: John A. Bird, MD, et al.
Published: (2025-08-01) -
Drug survival of omalizumab in atopic asthma: Impact of clinical and genetic variables
by: Susana Rojo-Tolosa, et al.
Published: (2025-12-01) -
A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data
by: A. S. Kolbin, et al.
Published: (2016-11-01)